Literature DB >> 7556332

Ceftriaxone-associated gallbladder lithiasis in children.

A Stabile, P Ferrara, G Marietti, G Maresca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7556332     DOI： 10.1007/bf02074846

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  9 in total

1.  Ceftriaxone-induced cholelithiasis.

Authors:  A J Lopez; P O'Keefe; M Morrissey; J Pickleman
Journal:  Ann Intern Med       Date:  1991-11-01       Impact factor: 25.391

2.  Reversible ceftriaxone-associated biliary pseudolithiasis in children.

Authors:  U B Schaad; J Wedgwood-Krucko; H Tschaeppeler
Journal:  Lancet       Date:  1988-12-17       Impact factor: 79.321

3.  Incidence of gallbladder lithiasis after ceftriaxone treatment.

Authors:  A Cometta; S Gallot-Lavallée-Villars; A Iten; L Cantoni; A Anderegg; J J Gonvers; M P Glauser
Journal:  J Antimicrob Chemother       Date:  1990-04       Impact factor: 5.790

4.  Ceftriaxone-associated cholecystitis.

Authors:  R F Jacobs
Journal:  Pediatr Infect Dis J       Date:  1988-06       Impact factor: 2.129

5.  A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children.

Authors:  U B Schaad; S Suter; A Gianella-Borradori; J Pfenninger; R Auckenthaler; O Bernath; J J Cheseaux; J Wedgwood
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

6.  Apparent biliary pseudolithiasis during ceftriaxone therapy.

Authors:  K L Heim-Duthoy; E M Caperton; R Pollock; G R Matzke; D Enthoven; P K Peterson
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 7.  Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

8.  Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children.

Authors:  M A del Rio; D Chrane; S Shelton; G H McCracken; J D Nelson
Journal:  Lancet       Date:  1983-06-04       Impact factor: 79.321

9.  Once daily ceftriaxone for central nervous system infections and other serious pediatric infections.

Authors:  R Yogev; S T Shulman; E G Chadwick; A T Davis; W Glogowski
Journal:  Pediatr Infect Dis       Date:  1986 May-Jun
  9 in total
  2 in total

1.  Acute necrotizing cholecystitis: a rare complication of ceftriaxone-associated pseudolithiasis.

Authors:  Sendia Kim; Kathleen M Gura; Mark Puder
Journal:  Pediatr Surg Int       Date:  2006-02-17       Impact factor: 1.827

Review 2.  Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.

Authors:  Harriet M Lamb; Douglas Ormrod; Lesley J Scott; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.